# Investigation Of A New Medication (GW642444) In Asthmatic Patients

> **NCT00354874** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 28 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** GW642444
- **DRUG:** Placebo
- **DRUG:** salmeterol 50mcg

## Key facts

- **NCT ID:** NCT00354874
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00354874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00354874, "Investigation Of A New Medication (GW642444) In Asthmatic Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00354874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*